Market Overview

A Peek Into The Market Before The Trading Starts

A Peek Into The Market Before The Trading Starts
Related USB
13F Season: A Look At Warren Buffett's Q1 Moves
Morningstar: Home Construction Boom Just Around The Corner
Morningstar: U.S. Bancorp's moat widens (Seeking Alpha)
Related AMRI
Albany Molecular Research Reports Deal with HarkerBIO for Buffalo, NY, No Terms Disclosed
Guidance Uncertainty Resolved At Albany Molecular Research, 2015 Margin Expansion Now In Focus

Pre-open movers US stock futures are higher this morning. Futures for the Dow Jones Industrial Average gained 27 points to 13,952.00 and S&P 500 index futures rose 2.70 points to 1,515.10. Nasdaq 100 futures climbed 4.25 points to 2,776.25.

A Peek Into Global Markets European markets were mostly higher today. The STOXX Europe 600 Index fell 0.36%, London's FTSE 100 Index gained 0.32%, German DAX 30 Index rose 0.05% and French CAC 40 Index climbed 0.38%.

Asian markets ended mostly lower, with Australia's S&P/ASX 200 Index dropping 0.18% and India's Sensex falling 0.12%.

Broker Recommendation Analysts at Stifel Nicolaus upgraded U.S. Bancorp (NYSE: USB) from “sell” to “hold.” The target price for U.S. Bancorp is set to $39.

U.S. Bancorp shares gained 0.77% to $33.91in pre-market trading.

Breaking news

  • AMRI (NASDAQ: AMRI) announced today that it has signed an exclusive license agreement with Chai Therapeutics, LLC for the development of ALB 109564(a), AMRI's novel tubulin inhibitor compound in late Phase I testing for the treatment of cancer. To read the full news, click here.
  • Brookfield Asset Management (NYSE: BAM) today announced the acquisition of portfolio of 19 apartment communities with 4,892 units located in North Carolina, South Carolina and Virginia for a total of $414 million from Babcock & Brown Residential. To read the full news, click here.
  • Science Applications International Corporation (SAIC) (NYSE: SAI) announced today it was awarded a prime contract by the United States Army to provide command, control, communications, computers, intelligence, surveillance and reconnaissance (C4ISR) rapid prototyping and technology insertion support to the Communications-Electronics Research Development & Engineering Center (CERDEC) Command, Power and Integration Directorate Prototyping, Integration and Testing Division. To read the full news, click here.
  • Life Technologies (NASDAQ: LIFE) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore® HLA typing kits. To read the full news, click here.

Posted-In: Stifel Nicolaus US Stock FuturesNews Futures Global Pre-Market Outlook Markets


Related Articles (AMRI + BAM)

Around the Web, We're Loving...

Get Benzinga's Newsletters